Close Menu

In an advance, online publication of Nucleic Acids Research this week, an international research team describes a novel role for miR-382, which they've uncovered using miRNA-target pairs in human renal epithelial cells treated with transforming growth factor β1. "Knockdown of miR-382, which was upregulated by TGFβ1, attenuated TGFβ1-induced loss of the epithelial marker E-cadherin," while "knockdown of miR-382 attenuated TGFβ1-induced downregulation of SOD2," the authors write.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.